ARTICLE | Company News
Biotest, Kedrion deal
February 8, 2016 8:00 AM UTC
Biotest granted Kedrion exclusive rights to commercialize Bivigam in the U.S. The polyspecific IV immune globulin is marketed in the U.S. to treat primary humoral immunodeficiency. The companies decl...